OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial
Désirée van der Heijde, Xenofon Baraliakos, Kay‐Geert Hermann, et al.
Annals of the Rheumatic Diseases (2018) Vol. 77, Iss. 5, pp. 699-705
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
Daniele Mauro, Ranjeny Thomas, Giuliana Guggino, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 7, pp. 387-404
Closed Access | Times Cited: 226

Treatment of axial spondyloarthritis: an update
Abhijeet Danve, Atul Deodhar
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 205-216
Closed Access | Times Cited: 92

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study
J. Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 5, pp. 859-868
Open Access | Times Cited: 131

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
Désirée van der Heijde, J. Braun, Atul Deodhar, et al.
Lara D. Veeken (2018) Vol. 58, Iss. 3, pp. 388-400
Open Access | Times Cited: 128

The IL-23–IL-17 pathway as a therapeutic target in axial spondyloarthritis
Joachim Sieper, Denis Poddubnyy, Pierre Miossec
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 12, pp. 747-757
Closed Access | Times Cited: 108

Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Boglárka Soós, Ágnes Szentpétery, Hennie G. Raterman, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 5, pp. 249-257
Closed Access | Times Cited: 42

Effects of waiting for outpatient physiotherapy services in persons with musculoskeletal disorders: a systematic review
Simon Deslauriers, Julien Déry, Ketsia Proulx, et al.
Disability and Rehabilitation (2019) Vol. 43, Iss. 5, pp. 611-620
Closed Access | Times Cited: 75

Radiographic progression in non-radiographic axial spondyloarthritis
Mikhail Protopopov, Denis Poddubnyy
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 6, pp. 525-533
Closed Access | Times Cited: 72

Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis
Paras Karmacharya, Alí Duarte‐García, Maureen Dubreuil, et al.
Arthritis & Rheumatology (2020) Vol. 72, Iss. 5, pp. 733-749
Open Access | Times Cited: 62

The role of imaging in the diagnosis and management of axial spondyloarthritis
Walter P. Maksymowych
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 11, pp. 657-672
Closed Access | Times Cited: 54

Structural progression in axial spondyloarthritis
K. Aouad, Nelly Ziadé, Xenofon Baraliakos
Joint Bone Spine (2019) Vol. 87, Iss. 2, pp. 131-136
Closed Access | Times Cited: 51

Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review
Xenofon Baraliakos, Lianne S. Gensler, Salvatore D’Angelo, et al.
Therapeutic Advances in Musculoskeletal Disease (2020) Vol. 12
Open Access | Times Cited: 49

Axial spondyloarthritis 10 years on: still looking for the lost tribe
Rosemarie Barnett, Thomas A Ingram, Raj Sengupta
Lara D. Veeken (2020) Vol. 59, Iss. Supplement_4, pp. iv25-iv37
Open Access | Times Cited: 42

To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis
Fabio Massimo Perrotta, Rik Lories, Ennio Lubrano
RMD Open (2021) Vol. 7, Iss. 1, pp. e001480-e001480
Open Access | Times Cited: 36

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
J. Braun, Ricardo Blanco, Helena Marzo‐Ortega, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 14

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
J. Braun, Hildrun Haibel, Manouk de Hooge, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 39

Treat to target in axial spondyloarthritis: From its concept to its implementation
Maxime Dougados
Journal of Autoimmunity (2020) Vol. 110, pp. 102398-102398
Open Access | Times Cited: 34

Uncovering the Underworld of Axial Spondyloarthritis
Sergio Del Vescovo, Vincenzo Venerito, Claudia Iannone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6463-6463
Open Access | Times Cited: 11

Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis
Patricia Remalante-Rayco, Emmanuel S. Baja, Zeynep Baskurt, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access

Non-radiographic versus radiographic axSpA: what’s in a name?
Xabier Michelena, Clementina López‐Medina, Helena Marzo‐Ortega
Lara D. Veeken (2020) Vol. 59, Iss. Supplement_4, pp. iv18-iv24
Open Access | Times Cited: 32

Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years
Désirée van der Heijde, Mikkel Østergaard, John D. Reveille, et al.
The Journal of Rheumatology (2021) Vol. 49, Iss. 3, pp. 265-273
Open Access | Times Cited: 24

“Long-term MRI findings in Ankylosing spondylitis patients treated with TNF inhibitors for a decade”
Aliki I. Venetsanopoulou, Nikoletta Anagnostou, Zoi Tziortzioti, et al.
Rheumatology International (2024) Vol. 44, Iss. 11, pp. 2583-2589
Closed Access | Times Cited: 3

Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification
İ̇̇smail Sarı, Nigil Haroon
Current Rheumatology Reports (2018) Vol. 20, Iss. 12
Closed Access | Times Cited: 28

The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019
Gustavo Gomes Resende, Eduardo de Souza Meirelles, Cláudia Diniz Lopes Marques, et al.
Advances in Rheumatology (2020) Vol. 60, Iss. 1
Open Access | Times Cited: 25

Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference
Alexandre Sepriano, Sofía Ramiro, Désirée van der Heijde, et al.
RMD Open (2021) Vol. 7, Iss. 2, pp. e001654-e001654
Open Access | Times Cited: 21

Page 1 - Next Page

Scroll to top